Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Archerdx, Bayer, Bluecross Blueshield of Tennessee, Caredx, Duality Technologies, Ekf Diagnostics, Integrated Computer Solutions, Lenovo, Lexent Bio, Progressive Care, Respiraworks, Senseonics, Transenterix, Tosoh Europe, Veracyte.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cardiologs, Exact Sciences, Icad, Pluristem Therapeutics, Tiziana Life Sciences.
LONDON – Geopolitical tensions over the issue of access to COVID-19 vaccines intensified this week, after the CEO of French pharmaceutical company Sanofi SA said the U.S. government would get first access to its product because it was first to fund the research.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abivax, Aim Immunotech, Cellphire, Enzychem, Immunic, Nordic Nanovector, Pharmazz, Restem, Sanofi, Scimount, Seattle Genetics, Takeda, Verona, Zealand.
DUBLIN – Abivax SA has rejected an acquisition offer in order to pursue a phase IIb/III trial of its lead anti-inflammatory drug ABX-464 in 1,034 COVID-19 patients.
Ventilators are not designed to sit in storage for long periods of time unused. But that’s precisely what’s often required of this medical device, which then may require substantial repair and updates before it is functional. That’s a tale that’s been told repeatedly in this pandemic.
The FDA’s weekly town hall on testing for the COVID-19 pandemic included the usual range of concerns about test performance, but concerns regarding swabs and sample sites continue to mount. The predicament has led to the announcement that the FDA along with the National Institutes of Health (NIH) will hold a May 15 town hall regarding swabs, with a particular interest in swabs produced via additive manufacturing.
RSS
